Valneva SE INRLF:OTCPK

*Data is delayed | Exchange | USD
Last | 04/17/24 EDT
3.85quote price arrow down-0.16 (-3.88%)
Volume
250
52 week range
3.35 - 8.55
Loading...
  • Open3.85
  • Day High3.85
  • Day Low3.85
  • Prev Close3.85
  • 52 Week High8.55
  • 52 Week High Date06/20/23
  • 52 Week Low3.35
  • 52 Week Low Date03/07/24

Key Stats

  • Market Cap592.95M
  • Shares Out138.79M
  • 10 Day Average Volume1,063
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-24.16

KEY STATS

  • Open3.85
  • Day High3.85
  • Day Low3.85
  • Prev Close3.85
  • 52 Week High8.55
  • 52 Week High Date06/20/23
  • 52 Week Low3.35
  • 52 Week Low Date03/07/24
  • Market Cap592.95M
  • Shares Out138.79M
  • 10 Day Average Volume1,063
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-24.16

RATIOS/PROFITABILITY

  • EPS (TTM)-0.66
  • P/E (TTM)-5.81
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Valneva SE

 

Profile

MORE
Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli...
Anne-Marie Graffin
Independent Chairman of the Board
Thomas Lingelbach
President, Chief Executive Officer, Director
Vincent Dequenne
Chief Operating Officer
Peter Buehler
Chief Financial Officer
Frederic Jacotot
General Counsel, Corporate Secretary
Address
6 rue Alain Bombard
Saint-herblain
44800
France